Metabolon Inc

Metabolon is the worldwide leader in metabolomics offering a global biochemical analysis of complex biological samples to deliver biomarkers and mechanistic insights into biochemical processes such as drug action, disease and cell culture conditions. Working extensively in the field of bioprocessing Metabolon has applied its platform to a wide range of applications including discovery of metabolites predictive of cell culture phenotypes and product quality, process optimization and design, media development, raw material analysis and mechanistic understanding of cell culture outputs. The result is increased product yield and quality with improved process reliability, reproducibility and lower process costs. Metabolon has conducted over 1,400 commercial projects for a loyal customer base of over 350 customers. Over 50 peer-reviewed articles have been published and 17 patents have been secured on its core technology. Please visit www.metabolon.com for more information.